MIMETAS partner in €4.5mn EU Interreg project BIOMAT | Mimetas

MIMETAS partner in €4.5mn EU Interreg project BIOMAT

MIMETAS partner in €4.5mn EU Interreg project BIOMAT

Engineering 3D microenvironments of vascularised bone and muscle

Funded by Interreg Vlaanderen - Nederland

The objective of the 'Biomat' project is to develop a platform for high-throughput testing of biomaterials in a physiologically relevant environment on-a-chip. The innovative aspects of this platform are a 3D environment that mimics relevant tissues in which novel and existing biomaterials can be integrated for reliable in vitro testing and monitoring.

Bones- and Muscles-on-a-Chip

Within this project, 3D microenvironments of vascularised bone and muscle will be engineered on microfluidic chips, and used to test the performance of biomaterials, such as hip implants, bone fillers and stents. MIMETAS OrganoPlate® technology offers unique functionalities, not possible with conventional 2D or 3D culture, allowing to better replicate the complex microenvironment of bones and muscles. In addition, MIMETAS's perfused vascular beds, that recapitulate hallmark features of human microvessels, will play an important role in the project. 

Within the first two years of Biomat-on-Microfluidic Chip project, important steps towards creating a new generation of patient-specific organ-on-chip platforms were taken by developing several engineering and biological technologies. 

  • First designs and models of the chip have been made in the form of inserts for culture plates. We have succeeded in forming three-dimensional biological micro-constructs of patient-specific cells and various biomaterials at micron scale. In addition to that, we have developed multiple robust bioassays for screening the toxicity/biocompatibility and the functionality of newly developed biomaterials.
  • Although this 3D model has been tested with human cell lines and stem cells, we have also optimized protocols for differentiating human-induced pluripotent stem cells (hiPSCs) towards muscle and bone tissues and for coupling these cells with reporters with which their growth and metabolism can be monitored non-invasively. Furthermore, we have shown the formation of 3D micro-tissues using these cells. 
  • The development of the platform for vascularization of 3D micro-tissues has also been demonstrated. 
  • In addition to that, we have developed a sensor that can be coupled to the chip in order to monitor tissue formation overtime.
  • We have developed a technology for fabrication of micro-biomaterials with different chemistries that can be screened in the platform for biocompatibility and biological functionality.

Partners and Funding